Početna › Dijabetes tipa 2 › Washington
Kliničke studije za Dijabetes tipa 2 u državi Washington
20 studija za Dijabetes tipa 2 traži sudionike na lokacijama u državi Washington.
Gradovi u državi Washington
Službeni tekst studije (engleski)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Universal Research Group, LLC, Tacoma
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- ERA Health Research - Redmond, Redmond
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Providence Regional Medical Center Everett, Everett
- University of Washington, Seattle
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 55 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT06112418Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
- Sleep and Performance Research Center, Spokane
U tijeku regrutacijaFaza 4Zdravi dobrovoljci dobrodošli
Od 18 do 45 godina · Oba spola · Ažurirano 18. ruj 2026. · NCT07494084A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Seattle
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Era Health Research, Redmond
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Eastside Research Associates, Redmond
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- The Vancouver Clinic, Vancouver
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Renton
- Research Site, Seattle
- Research Site, Seattle
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Seattle Children's Research Institute, Seattle
U tijeku regrutacijaFaza 3
Od 10 do 18 godina · Oba spola · Ažurirano 9. ruj 2026. · NCT07282613A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Northwest Clinical Research Center, Bellevue
- Rainier Clinical Research Center, Renton
- Universal Research Group, Tacoma
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT07215559A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Redmond
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Renton
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Renton
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT07606066A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Seattle Children's Hospital, Seattle
U tijeku regrutacijaFaza 3
Od 10 do 17 godina · Oba spola · Ažurirano 7. kol 2026. · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Renton
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 4. kol 2026. · NCT07664553ROME GS System Study
- Rainier Clinical Research Center, Renton
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 21. tra 2026. · NCT07518004Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
- Seattle Children's Hospital, Seattle
- University of Washington Medicine Diabetes Institute, Seattle
U tijeku regrutacija
Od 14 do 40 godina · Oba spola · Ažurirano 13. lip 2025. · NCT06936670Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
- Seattle Children's Hospital, Seattle
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 8 do 14 godina · Oba spola · Ažurirano 24. ožu 2025. · NCT05008276Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- University of Washington - Harborview Medical Center, Seattle
U tijeku regrutacijaFaza 4
Od 40 do 65 godina · Oba spola · Ažurirano 5. lip 2024. · NCT05780905Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.